Public-Private Entrepreneurship

The Netherlands excels in developing regenerative medicine, where the body's self-healing ability is stimulated. That is why government bodies support the RegMed XB's mission to deliver affordable regenerative medicine solutions to patients while building a competitive and sustainable industry.

For example, the Subsidieregeling Regeneratief Geneeskundige Onderzoeksprojecten (SRGO) helps to enhance collaboration between science and SMEs. This subsidy scheme is funded by the Ministry of Economic Affairs and Climate Policy and the Ministry of Health, Welfare, and Sport and will be executed by the Netherlands Enterprise Agency (RVO).

Programme funding public private (RegMed XB projects)

The last round of funding was amended SRGO (Subsidieregeling Regeneratief Geneeskundige Onderzoeksprojecten) in the Staatscourant on 21-11-2025, with a total budget of 10 million euro for innovative public-private projects in the field of regenerative medicine, this tender closed at 17 February 2026 at 17:00.

More details, visit the RVO website: https://www.rvo.nl/subsidies-financiering/srgo

Additionally, the regions of Brabant, Utrecht, South Holland, and Limburg are making significant investments in seed capital and infrastructure to support start-ups and production development.

Together, these initiatives are creating a world-class regenerative medicine ecosystem, accelerating the RegMed XB Moonshots and delivering tangible benefits to Dutch society and regional economies. All made possible by Public-Private Entrepreneurship Fund and Strategic public-private partnerships (PPPs), which provides project finance loans to stimulate collaborative ventures.